{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:04:50Z","timestamp":1774775090112,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["DAP is a Senior Investigator"],"award-info":[{"award-number":["DAP is a Senior Investigator"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["11\/0004319"],"award-info":[{"award-number":["11\/0004319"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00125-018-4651-x","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T07:02:59Z","timestamp":1528354979000},"page":"1794-1803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes"],"prefix":"10.1007","volume":"61","author":[{"given":"Wendy E.","family":"Powell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire N.","family":"Hocter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J.","family":"Dunseath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Luzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Farewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin M.","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Ladell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2812-8845","authenticated-orcid":false,"given":"F. Susan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"4651_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/dc13-0626","volume":"37","author":"MD Pescovitz","year":"2014","unstructured":"Pescovitz MD, Greenbaum CJ, Bundy B et al (2014) B-lymphocyte depletion with rituximab and \u03b2-cell function: two-year results. Diabetes Care 37:453\u2013459","journal-title":"Diabetes Care"},{"key":"4651_CR2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1172\/JCI116835","volume":"92","author":"N Itoh","year":"1993","unstructured":"Itoh N, Hanafusa T, Miyazaki A et al (1993) Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus individuals. J Clin Invest 92:2313\u20132322","journal-title":"J Clin Invest"},{"key":"4651_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","volume":"155","author":"A Willcox","year":"2009","unstructured":"Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173\u2013181","journal-title":"Clin Exp Immunol"},{"key":"4651_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4049\/jimmunol.1102176","volume":"188","author":"T Habib","year":"2012","unstructured":"Habib T, Funk A, Rieck M et al (2012) Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol 188:487\u2013496","journal-title":"J Immunol"},{"key":"4651_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/cei.12362","volume":"177","author":"WS Thompson","year":"2014","unstructured":"Thompson WS, Pekalski ML, Simons HZ et al (2014) Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes. Clin Exp Immunol 177:571\u2013585","journal-title":"Clin Exp Immunol"},{"key":"4651_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2337\/db16-0714","volume":"66","author":"T Viisanen","year":"2017","unstructured":"Viisanen T, Ihantola EL, N\u00e4nt\u00f6-Salonen K et al (2017) Circulating CXCR5+PD-1+ICOS+ follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies. Diabetes 66:437\u2013447","journal-title":"Diabetes"},{"key":"4651_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2337\/dc15-1765","volume":"39","author":"C Deng","year":"2016","unstructured":"Deng C, Xiang Y, Tan T et al (2016) Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 39:434\u2013440","journal-title":"Diabetes Care"},{"key":"4651_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2337\/db13-1639","volume":"64","author":"S Kleffel","year":"2015","unstructured":"Kleffel S, Vergani A, Tezza S et al (2015) Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes 64:158\u2013171","journal-title":"Diabetes"},{"key":"4651_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2337\/db13-1798","volume":"64","author":"MJ Smith","year":"2015","unstructured":"Smith MJ, Packard TA, O\u2019Neill SK et al (2015) Loss of anergic B cells in prediabetic and new-onset type 1 diabetic individuals. Diabetes 64:1703\u20131712","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"4651_CR10","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.2337\/dc08-S012","volume":"31","author":"American Diabetes Association","year":"2008","unstructured":"American Diabetes Association (2008) Standards of medical care in diabetes\u20142008. Diabetes Care 31(Suppl 1):S12\u2013S54","journal-title":"Diabetes Care"},{"key":"4651_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/7651_2015_307","volume":"1433","author":"RJ Aitken","year":"2016","unstructured":"Aitken RJ, Mortimer GL, Gillespie KM (2016) Type 1 diabetes high-risk HLA class II determination by polymerase chain reaction sequence-specific primers. Methods Mol Biol 1433:13\u201320","journal-title":"Methods Mol Biol"},{"key":"4651_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nprot.2016.066","volume":"11","author":"B Anchang","year":"2016","unstructured":"Anchang B, Hart TD, Bendall SC et al (2016) Visualization and cellular hierarchy inference of single-cell data using SPADE. Nat Protoc 11:1264\u20131279","journal-title":"Nat Protoc"},{"key":"4651_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cyto.a.23068","volume":"91","author":"P Qiu","year":"2017","unstructured":"Qiu P (2017) Toward deterministic and semiautomated SPADE analysis. Cytometry A 91:281\u2013289","journal-title":"Cytometry A"},{"key":"4651_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nri.2016.56","volume":"16","author":"Y Saeys","year":"2016","unstructured":"Saeys Y, Van Gassen S, Lambrecht BN (2016) Computational flow cytometry: helping to make sense of high-dimensional immunology data. Nat Rev Immunol 16:449\u2013462","journal-title":"Nat Rev Immunol"},{"key":"4651_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.imlet.2017.04.009","volume":"189","author":"Z Parackova","year":"2017","unstructured":"Parackova Z, Klocperk A, Rataj M et al (2017) Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric individuals with type 1 diabetes. Immunol Lett 189:94\u2013100","journal-title":"Immunol Lett"},{"key":"4651_CR16","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood-2007-03-081232","volume":"111","author":"G Badr","year":"2008","unstructured":"Badr G, Borhis G, Lefevre EA et al (2008) BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111:2744\u20132754","journal-title":"Blood"},{"key":"4651_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1600-065X.2010.00938.x","volume":"237","author":"T Yoshida","year":"2010","unstructured":"Yoshida T, Mei H, Dorner T et al (2010) Memory B and memory plasma cells. Immunol Rev 237:117\u2013139","journal-title":"Immunol Rev"},{"key":"4651_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2012.00302","volume":"3","author":"DA Kaminski","year":"2012","unstructured":"Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I (2012) Advances in human B cell phenotypic profiling. Front Immunol 3:302","journal-title":"Front Immunol"},{"key":"4651_CR19","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.2337\/diabetes.51.8.2474","volume":"51","author":"T Lohmann","year":"2002","unstructured":"Lohmann T, Laue S, Nietzschmann U et al (2002) Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 51:2474\u20132480","journal-title":"Diabetes"},{"key":"4651_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1196\/annals.1375.029","volume":"1079","author":"S Yamada","year":"2006","unstructured":"Yamada S, Oikawa Y, Sakai G, Atsumi Y, Maruyama T, Shimada A (2006) Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes. Ann N Y Acad Sci 1079:186\u2013189","journal-title":"Ann N Y Acad Sci"},{"key":"4651_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.4049\/jimmunol.169.3.1277","volume":"169","author":"AE Hauser","year":"2002","unstructured":"Hauser AE, Debes GF, Arce S et al (2002) Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 169:1277\u20131282","journal-title":"J Immunol"},{"key":"4651_CR22","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1182\/blood-2004-08-2992","volume":"105","author":"G Muehlinghaus","year":"2005","unstructured":"Muehlinghaus G, Cigliano L, Huehn S et al (2005) Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105:3965\u20133971","journal-title":"Blood"},{"key":"4651_CR23","doi-asserted-by":"publisher","first-page":"R1001","DOI":"10.1186\/ar1776","volume":"7","author":"M Henneken","year":"2005","unstructured":"Henneken M, D\u00f6rner T, Burmester GR, Berek C (2005) Differential expression of chemokine receptors on peripheral blood B cells from individuals with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 7:R1001\u2013R1013","journal-title":"Arthritis Res Ther"},{"key":"4651_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clim.2015.06.013","volume":"160","author":"M Vlkova","year":"2015","unstructured":"Vlkova M, Ticha O, Nechvatalova J et al (2015) Regulatory B cells in CVID individuals fail to suppress multifunctional IFN-\u03b3+TNF-\u03b1+CD4+ T cells differentiation. Clin Immunol 160:292\u2013300","journal-title":"Clin Immunol"},{"key":"4651_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Nore\u00f1a LY, Flores-Borja F et al (2010) CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus individuals. Immunity 32:129\u2013140","journal-title":"Immunity"},{"key":"4651_CR26","doi-asserted-by":"publisher","first-page":"e0128269","DOI":"10.1371\/journal.pone.0128269","volume":"10","author":"DG Adlowitz","year":"2015","unstructured":"Adlowitz DG, Barnard J, Biear JN et al (2015) Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response. PLoS One 10:e0128269","journal-title":"PLoS One"},{"key":"4651_CR27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.clim.2017.09.021","volume":"183","author":"P Hanley","year":"2017","unstructured":"Hanley P, Sutter JA, Goodman NG et al (2017) Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes. Clin Immunol 183:336\u2013343","journal-title":"Clin Immunol"},{"key":"4651_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","volume":"27","author":"C Mauri","year":"2015","unstructured":"Mauri C, Menon M (2015) The expanding family of regulatory B cells. Int Immunol 27:479\u2013486","journal-title":"Int Immunol"},{"key":"4651_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cea.12238","volume":"44","author":"LE Vlugt van der","year":"2014","unstructured":"van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A et al (2014) CD24hiCD27+ B cells from individuals with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy 44:517\u2013528","journal-title":"Clin Exp Allergy"},{"key":"4651_CR30","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","volume":"25","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Fallahi P, Ferrari SM et al (2008) Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study. Diabet Med 25:1349\u20131353","journal-title":"Diabet Med"},{"key":"4651_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.24.3.510","volume":"24","author":"A Shimada","year":"2001","unstructured":"Shimada A, Morimoto J, Kodama K et al (2001) Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24:510\u2013515","journal-title":"Diabetes Care"},{"key":"4651_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00125-002-0879-5","volume":"45","author":"F Nicoletti","year":"2002","unstructured":"Nicoletti F, Conget I, Di Mauro M et al (2002) Serum concentrations of the interferon-\u03b3-inducible chemokine IP-10\/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus individuals and subjects at risk of developing the disease. Diabetologia 45:1107\u20131110","journal-title":"Diabetologia"},{"key":"4651_CR33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2249.2008.03720.x","volume":"153","author":"M Hedman","year":"2008","unstructured":"Hedman M, Faresj\u00f6 M, Axelsson S, Ludvigsson J, Casas R (2008) Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children. Clin Exp Immunol 153:360\u2013368","journal-title":"Clin Exp Immunol"},{"key":"4651_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","volume":"25","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P (2014) CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev 25:57\u201365","journal-title":"Cytokine Growth Factor Rev"},{"key":"4651_CR35","doi-asserted-by":"publisher","first-page":"e0174840","DOI":"10.1371\/journal.pone.0174840","volume":"12","author":"K Waugh","year":"2017","unstructured":"Waugh K, Snell-Bergeon J, Michels A et al (2017) Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). PLoS One 12:e0174840","journal-title":"PLoS One"},{"key":"4651_CR36","doi-asserted-by":"publisher","first-page":"30219","DOI":"10.1074\/jbc.M403595200","volume":"279","author":"RA Colvin","year":"2004","unstructured":"Colvin RA, Campanella GSV, Sun J, Luster AD (2004) Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem 279:30219\u201330227","journal-title":"J Biol Chem"},{"key":"4651_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood-2007-10-118497","volume":"112","author":"AE Cardona","year":"2008","unstructured":"Cardona AE, Sasse ME, Liu L et al (2008) Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112:256\u2013263","journal-title":"Blood"},{"key":"4651_CR38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2337\/db11-0853","volume":"61","author":"SA Sarkar","year":"2012","unstructured":"Sarkar SA, Lee CE, Victorino F et al (2012) Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 61:436\u2013446","journal-title":"Diabetes"},{"key":"4651_CR39","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nm1202-792","volume":"8","author":"S Frigerio","year":"2002","unstructured":"Frigerio S, Junt T, Lu B et al (2002) \u03b2 cells are responsible for CXCR3-mediated T cell infiltration in insulitis. Nat Med 8:1414\u20131420","journal-title":"Nat Med"},{"key":"4651_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom JR, Luster AD (2011) CXCR3 in T cell function. Exp Cell Res 317:620\u2013631","journal-title":"Exp Cell Res"},{"key":"4651_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","volume":"128","author":"J Krejcik","year":"2016","unstructured":"Krejcik J, Casneuf T, Nijhof IS et al (2016) Daratumumab depletes CD38+ immune regulatory cells, promotes T cell expansion, and skews T cell repertoire in multiple myeloma. Blood 128:384\u2013394","journal-title":"Blood"},{"key":"4651_CR42","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/eji.200939314","volume":"39","author":"Z Shi","year":"2009","unstructured":"Shi Z, Okuno Y, Rifa\u2019i M et al (2009) Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol 39:2106\u20132119","journal-title":"Eur J Immunol"},{"key":"4651_CR43","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/eji.201343751","volume":"43","author":"YD Mahnke","year":"2013","unstructured":"Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E (2013) The who\u2019s who of T cell differentiation: human memory T cell subsets. Eur J Immunol 43:2797\u20132809","journal-title":"Eur J Immunol"},{"key":"4651_CR44","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2337\/diabetes.50.4.752","volume":"50","author":"R Mallone","year":"2001","unstructured":"Mallone R, Ortolan E, Baj G et al (2001) Autoantibody response to CD38 in Caucasian individuals with type 1 and type 2 diabetes: immunological and genetic characterization. Diabetes 50:752\u2013762","journal-title":"Diabetes"},{"key":"4651_CR45","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/eji.201344186","volume":"44","author":"E Mari\u00f1o","year":"2014","unstructured":"Mari\u00f1o E, Walters SN, Villanueva JE, Richards JL, Mackay CR, Grey ST (2014) BAFF regulates activation of self-reactive T cells through B cell dependent mechanisms and mediates protection in NOD mice. Eur J Immunol 44:983\u2013993","journal-title":"Eur J Immunol"},{"key":"4651_CR46","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.4049\/jimmunol.181.11.8133","volume":"181","author":"G Zekavat","year":"2008","unstructured":"Zekavat G, Rostami SY, Badkerhanian A et al (2008) In vivo BLyS\/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol 181:8133\u20138144","journal-title":"J Immunol"},{"key":"4651_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.autrev.2009.07.005","volume":"9","author":"M Fabris","year":"2010","unstructured":"Fabris M, Grimaldi F, Villalta D et al (2010) BLyS and April serum levels in individuals with autoimmune thyroid diseases. Autoimmun Rev 9:165\u2013169","journal-title":"Autoimmun Rev"},{"key":"4651_CR48","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cyto.2015.07.014","volume":"76","author":"F Wei","year":"2015","unstructured":"Wei F, Chang Y, Wei W (2015) The role of BAFF in the progression of rheumatoid arthritis. Cytokine 76:537\u2013544","journal-title":"Cytokine"},{"key":"4651_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejcb.2017.02.001","volume":"96","author":"C Sun","year":"2017","unstructured":"Sun C, Zhu X, Tao T et al (2017) The \u03b24GalT1 affects the fibroblast-like synoviocytes invasion in rheumatoid arthritis by modifying N-linked glycosylation of CXCR3. Eur J Cell Biol 96:172\u2013181","journal-title":"Eur J Cell Biol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4651-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4651-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T09:47:44Z","timestamp":1720345664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4651-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4651"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4651-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"14 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}